[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …
[HTML][HTML] Percentage of asymptomatic infections among SARS-CoV-2 omicron variant-positive individuals: a systematic review and meta-analysis
W Shang, L Kang, G Cao, Y Wang, P Gao, J Liu, M Liu - Vaccines, 2022 - mdpi.com
Background: Asymptomatic infections are potential sources of transmission for coronavirus
disease 2019, especially during the epidemic of the SARS-CoV-2 Omicron variant. We …
disease 2019, especially during the epidemic of the SARS-CoV-2 Omicron variant. We …
[HTML][HTML] Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron
Abstract The Omicron (B. 1.1. 529) variant of SARS-CoV-2 emerged in November 2021 and
is rapidly spreading among the human population. Although recent reports reveal that the …
is rapidly spreading among the human population. Although recent reports reveal that the …
Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants
EK Accorsi, A Britton, KE Fleming-Dutra, ZR Smith… - Jama, 2022 - jamanetwork.com
Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-
CoV-2 Omicron variant is critical to inform public health guidance. Objective To estimate the …
CoV-2 Omicron variant is critical to inform public health guidance. Objective To estimate the …
[HTML][HTML] COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron …
AG Johnson - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
In 25 US jurisdictions, decreases in case incidence rate ratios for unvaccinated versus fully
vaccinated persons with and without booster vaccine doses were observed when the …
vaccinated persons with and without booster vaccine doses were observed when the …
[HTML][HTML] Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022
KJ Marks - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Coinciding with increased circulation of the Omicron variant, COVID-19–associated
hospitalization rates among children and adolescents aged 0–17 years increased rapidly in …
hospitalization rates among children and adolescents aged 0–17 years increased rapidly in …
[HTML][HTML] Investigation of a SARS-CoV-2 B. 1.1. 529 (omicron) variant cluster—Nebraska, November–December 2021
L Jansen - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
The B. 1.1. 529 (Omicron) variant of SARS-CoV-2 (the virus that causes COVID-19) was first
detected in specimens collected on November 11, 2021, in Botswana and on November 14 …
detected in specimens collected on November 11, 2021, in Botswana and on November 14 …
[HTML][HTML] Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
Abstract The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear
need for high-throughput, multiplexed and sensitive assays for detecting severe acute …
need for high-throughput, multiplexed and sensitive assays for detecting severe acute …
[PDF][PDF] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …
emerged in November 2021 and consists of several mutations within the spike. We use …
[PDF][PDF] Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
V Servellita, AM Syed, MK Morris, N Brazer, P Saldhi… - Cell, 2022 - cell.com
Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity
against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated …
against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated …